Leuprolide 2WK 14 MG/2.8 ML KTS
Ended Awarded
- Contract number
- SPE2DR26FQP4T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,906
Award facts
- Contract value 100% obligated
- $34,905.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,905.96 to AmerisourceBergen Drug Corp for the supply of Leuprolide 2-week 14 mg/2.8 ml kits, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying a vast range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, has demonstrated substantial capability in fulfilling federal medical procurement requirements through consistent competitive awards from the Defense Logistics Agency. The company's contract portfolio includes delivery of specialty pharmaceuticals, vaccines, generic and brand-name medications, and medical devices across multiple therapeutic domains. This award of leuprolide, a hormone treatment used primarily in oncology and urology applications, aligns with AmerisourceBergen's established role as a critical vendor supporting Defense Health Agency and military healthcare system needs through flexible contract mechanisms designed to ensure reliable supply chain support for federal medical programs.
Quick answers
Who was awarded contract SPE2DR26FQP4T?
SPE2DR26FQP4T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FQP4T worth?
The government has obligated $34,906 on SPE2DR26FQP4T.
Is contract SPE2DR26FQP4T an order under another contract?
Yes. SPE2DR26FQP4T is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP4T competed?
The extent of competition for SPE2DR26FQP4T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award